Trial NCT03396471

View at ClinicalTrials.gov 
Org. Study IDs: HCRN CUP16-268

Last trial update was posted on 2024-04-18

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma

Other Conditions

Carcinoma, Unspecified Site

Stopping Reasons

Study failed to meet its interim analysis endpoint

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID